In May of 2007, Houston-based Cyberonics attempted to reach out to the Centers for Medicare and Medicaid Services (CMS) in order to receive approval for the use of their Vagus Nerve Stimulation (VNS) therapy system for the treatment of those that receive Medicare and suffer from treatment-resistant depression (TRD). The preliminary determination at that time was to deny Medicare patients with TRD any coverage for VNS therapy.
http://bionews-tx.com/news/2013/04/04/houston-based-cyberonics-dialog-with-medicaid-regarding-vns-still-ongoing/
No comments:
Post a Comment